Clinical Trial Update: Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene Mutations [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing rostafuroxin to losartan in hypertensive patients with specified gene mutations to evaluate antihypertensive effects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Losartan (losartan)
• Rostafuroxin (rostafuroxin)

Snippet

Sponsor: RostaQuo S.p.A. | Conditions: Essential Hypertension | Phase 2 | Status: UNKNOWN